UnitedHealth Group reported its third-quarter 2026 results on 13 October 2026, posting a medical-cost ratio of 88.4% and earnings that exceeded analyst estimates. The company simultaneously raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share, up from a prior range of $19.50–$20.00 per share, citing effective management of medical costs.
UnitedHealth Group's common stock (UNH) is directly tied to this earnings release, as the revised guidance figure of at least $20.50 per share in adjusted earnings represents a material change from the company's previously stated range and affects the basis on which the stock is assessed by market participants.
No official regulatory statement or third-party government response to the earnings release was reported in the cluster sources at the time of publication.
Sources: Marketwatch TOP, Cnbc TOP, CNBC